Physician profile
Caitlin Lund
NPI 1649790403
$14,013.72
in general payments reported to CMS, 2019-2025
14 companies · $22.13 in 2025
The $22.13 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.62 · 2021: $111 · 2022: $11K · 2023: $3,148 · 2024: $55.73 · 2025: $22.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $225.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,449.28 | 2022-2023 | Davinci Xi |
| Conmed Corporation | $141.64 | 2022 | |
| Boston Scientific Corporation | $140.37 | 2021-2023 | Spyglass |
| Tela Bio, INC. | $38.89 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $36.59 | 2024 | Exparel |
| Smith+Nephew, INC. | $33.18 | 2023 | Grafix Pl, Stravix |
| Edwards Lifesciences Corporation | $26.62 | 2019 | |
| Csl Behring | $24.99 | 2023 | Kcentra |
| Urgo Medical North America, LLC | $22.60 | 2022 | |
| Merck Sharp & Dohme LLC | $22.13 | 2025 | Bridion |
| Takeda Pharmaceuticals U.S.A., INC. | $20.72 | 2023 | Gattex |
| Braintree Laboratories, INC. | $20.48 | 2022 | |
| Davol INC. | $19.14 | 2024 | Phasix Mesh |
| Kci USA, INC. | $17.09 | 2023 | V.A.C. Veraflo, Abthera, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Lund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.